RT Journal Article
SR Electronic
T1 IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003924
DO 10.1136/jitc-2021-003924
VO 10
IS 3
A1 Yap, Timothy A
A1 Bessudo, Alberto
A1 Hamilton, Erika
A1 Sachdev, Jasgit
A1 Patel, Manish R
A1 Rodon, Jordi
A1 Evilevitch, Lena
A1 Duncan, Meghan
A1 Guo, Wei
A1 Kumar, Sujatha
A1 Lu, Sharon
A1 Dezube, Bruce J
A1 Gabrail, Nashat
YR 2022
UL http://jitc.bmj.com/content/10/3/e003924.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.